ENDRA LIFE SCIENCES INC. Proceeds from Issuance of Warrants
ENDRA LIFE SCIENCES INC. (NDRA) reported Proceeds from Issuance of Warrants of $3.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. proceeds from issuance of warrants for the quarter ending 2024-12-31 was -$1.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of warrants for the quarter ending 2024-09-30 was $1.32M.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of warrants for the quarter ending 2023-12-31 was $1.01M.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of warrants for the quarter ending 2023-09-30 was $0.00.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of warrants for fiscal 2024 was $1.32M, a 27.60% increase from fiscal 2023.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of warrants for fiscal 2023 was $1.03M.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of warrants for fiscal 2022 was $0.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 9 month as first filed | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.80M 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.32M derived: sum of 2 quarters · filed 2026-03-31 | $1.32M 10-K · filed 2026-03-31 | $6.69M 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.32M 10-Q · filed 2025-11-14 | $5.37M 10-Q/A · filed 2024-11-21 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | |||||
| 2023-12-31 | $1.01M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | $1.01M derived: sum of 2 quarters · filed 2025-04-07 | $1.03M 10-K/A · filed 2025-04-07 | $20.05K 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21 | $20.05K 10-Q/A · filed 2024-11-21 | ||||
| 2023-06-30 | $20.05K 10-Q · filed 2024-08-14 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |